ArticleJournal of managed care & specialty pharmacy2023

Real-world impact of empagliflozin on total cost of care in adults with type 2 diabetes: Results from an outcomes-based agreement.

Samuel K Peasah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.